
Phase I/II study in cancer patients showcases eClinical effectiveness.
Chief Commercial Officer, IDDI Group
Phase I/II study in cancer patients showcases eClinical effectiveness.
Examining how to optimizing the time and effort of Ethics Committees to efficiently and effectively fulfill their human subjects protection remit.
Published: August 14th 2020 | Updated: